Although the exact mechanism of the RAC1-mediated development of resistance is not clear, the role of RAC1 will be interesting to study considering the relationship of tumor cell metabolism and the production of ROS following radiation, DNA-damaging agents, and various chemotherapeutic agents. Here, RAC1 is linked to neoplasm.